Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2010

01-10-2010 | Case Report

Successful initiation and maintenance of hemodialysis in an adult patient with complete transposition of the great arteries

Authors: Shunsuke Yamada, Hideki Yotsueda, Masatomo Taniguchi, Kazuhiko Tsuruya, Hideki Hirakata, Mitsuo Iida

Published in: Clinical and Experimental Nephrology | Issue 5/2010

Login to get access

Abstract

Cyanotic congenital heart disease (CCHD) is a life-threatening cardiac defect that requires palliative or corrective surgery in early life. Major advances in medical and surgical management have resulted in the survival of CCHD patients to adulthood with or without corrective surgery, though some are at risk of development of end-stage renal disease (ESRD) due to cyanotic nephropathy (CN). There is little or no information on the initiation and maintenance of hemodialysis (HD) in such patients. We present here a case of a 44-year-old man with complete transposition of the great arteries and CN-related ESRD. He had only received a bi-directional Glenn’s operation and still suffered persistent severe hypoxemia and impaired cardiac function. ESRD was successfully treated with HD over more than 4 years. The case emphasizes the need for special attention in the selection and initiation of renal replacement therapy.
Literature
1.
go back to reference Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier-Sunders; 2005. p. 1525–8. Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier-Sunders; 2005. p. 1525–8.
2.
go back to reference Sakazaki H, Niwa K, Echigo S, Akagi T, Nakazawa M. Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease—Japanese multi-center study. Int J Cardiol. 2007;120:72–8.CrossRefPubMed Sakazaki H, Niwa K, Echigo S, Akagi T, Nakazawa M. Predictive factors for long-term prognosis in adults with cyanotic congenital heart disease—Japanese multi-center study. Int J Cardiol. 2007;120:72–8.CrossRefPubMed
3.
go back to reference Perloff JK, Latta H, Barsotti P. Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol. 2000;86:1198–204.CrossRefPubMed Perloff JK, Latta H, Barsotti P. Pathogenesis of the glomerular abnormality in cyanotic congenital heart disease. Am J Cardiol. 2000;86:1198–204.CrossRefPubMed
4.
go back to reference Mostafa SS, Miller WM, Papoutsakis ET. Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocyte. Br J Haematol. 2000;111:879–89.CrossRefPubMed Mostafa SS, Miller WM, Papoutsakis ET. Oxygen tension influences the differentiation, maturation and apoptosis of human megakaryocyte. Br J Haematol. 2000;111:879–89.CrossRefPubMed
5.
go back to reference Nakanishi K, Tajima F, Osada H, Kato T, Kawai T, Torikata C, et al. Thrombopoietin expression in normal and hypobaric hypoxia-induced thrombocytopenic rats. Lab Investig. 1999;79:679–88.PubMed Nakanishi K, Tajima F, Osada H, Kato T, Kawai T, Torikata C, et al. Thrombopoietin expression in normal and hypobaric hypoxia-induced thrombocytopenic rats. Lab Investig. 1999;79:679–88.PubMed
6.
go back to reference Muto S, Asano Y, Hosoda S, Shinoya S, Miura Y, Urabe A, et al. Polycythemia of end-stage renal failure: no inhibition of erythropoiesis by uremic serum and markedly increased serum erythropoietin level. Nephron. 1987;46:34–6.CrossRefPubMed Muto S, Asano Y, Hosoda S, Shinoya S, Miura Y, Urabe A, et al. Polycythemia of end-stage renal failure: no inhibition of erythropoiesis by uremic serum and markedly increased serum erythropoietin level. Nephron. 1987;46:34–6.CrossRefPubMed
7.
go back to reference Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier-Sunders; 2005. p. 1489–505. Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s heart disease: a textbook of cardiovascular medicine. 7th ed. Philadelphia: Elsevier-Sunders; 2005. p. 1489–505.
8.
go back to reference Niwa K, Perloff JK, Webb GD, Murphy D, Liberthson R, Warnes CA, et al. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol. 2004;92:211–6.CrossRef Niwa K, Perloff JK, Webb GD, Murphy D, Liberthson R, Warnes CA, et al. Survey of specialized tertiary care facilities for adults with congenital heart disease. Int J Cardiol. 2004;92:211–6.CrossRef
9.
go back to reference Perloff JK, Rosove MH, Sietsema KE, Territo MC. Cyanotic congenital heart disease: a multisystem disorder. In: Perloff JK, Child JS, editors. Congenital heart disease in adults. 2nd ed. Philadelphia: WB Saunders; 1998. p. 199–226. Perloff JK, Rosove MH, Sietsema KE, Territo MC. Cyanotic congenital heart disease: a multisystem disorder. In: Perloff JK, Child JS, editors. Congenital heart disease in adults. 2nd ed. Philadelphia: WB Saunders; 1998. p. 199–226.
10.
go back to reference Di Fillipo S, Delahaye F, Semiond B, Celard M, Henaine R, Ninet J, et al. Current patterns of infective endocarditis in congenital heart disease. Heart. 2006;92:1490–5.CrossRef Di Fillipo S, Delahaye F, Semiond B, Celard M, Henaine R, Ninet J, et al. Current patterns of infective endocarditis in congenital heart disease. Heart. 2006;92:1490–5.CrossRef
11.
go back to reference Segall L, Covic A. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis. Nephrol Dial Transplant. 2007;22:59–637.CrossRefPubMed Segall L, Covic A. Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro haemodialysis. Nephrol Dial Transplant. 2007;22:59–637.CrossRefPubMed
12.
go back to reference Ohira S, Naito H, Amano I, Azuma N, Ikeda K, Kukita K, et al. 2005 Japanese society for dialysis therapy guidelines for vascular access construction and repair for chronic hemodialysis. Ther Apher Dial. 2006;10:449–62.CrossRefPubMed Ohira S, Naito H, Amano I, Azuma N, Ikeda K, Kukita K, et al. 2005 Japanese society for dialysis therapy guidelines for vascular access construction and repair for chronic hemodialysis. Ther Apher Dial. 2006;10:449–62.CrossRefPubMed
13.
go back to reference Salim MA, Case CL, Sade RM, Watson DC, Alpert BS, DiSessa TG. Pulmonary/systemic flow ratio in children after cavopulmonary anastomosis. J Am Coll Cardiol. 1995;25:735–8.CrossRefPubMed Salim MA, Case CL, Sade RM, Watson DC, Alpert BS, DiSessa TG. Pulmonary/systemic flow ratio in children after cavopulmonary anastomosis. J Am Coll Cardiol. 1995;25:735–8.CrossRefPubMed
14.
go back to reference Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K. Mechanism of development and progression of cyanotic nephropathy. Pediatr Nephrol. 2006;10:1440–5.CrossRef Inatomi J, Matsuoka K, Fujimaru R, Nakagawa A, Iijima K. Mechanism of development and progression of cyanotic nephropathy. Pediatr Nephrol. 2006;10:1440–5.CrossRef
15.
go back to reference Hida K, Wada J, Yamasaki H, Nagake Y, Zhang H, Sugiyama H, et al. Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor. Nephrol Dial Transplant. 2002;17:144–7.CrossRefPubMed Hida K, Wada J, Yamasaki H, Nagake Y, Zhang H, Sugiyama H, et al. Cyanotic congenital heart disease associated with glomerulomegaly and focal segmental glomerulosclerosis: remission of nephrotic syndrome with angiotensin converting enzyme inhibitor. Nephrol Dial Transplant. 2002;17:144–7.CrossRefPubMed
16.
go back to reference Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, et al. Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin converting enzyme inhibitor. Clin Nephrol. 2002;58:95–102.PubMed Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, et al. Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin converting enzyme inhibitor. Clin Nephrol. 2002;58:95–102.PubMed
17.
go back to reference Takahashi S, Ooya K, Wada N, Inagaki T, Takana Y, Saito A, et al. Partial exchange transfusion improved renal function and proteinuria in a patient with cyanotic heart disease nephropathy. Clin Nephrol. 2003;60:222–3.PubMed Takahashi S, Ooya K, Wada N, Inagaki T, Takana Y, Saito A, et al. Partial exchange transfusion improved renal function and proteinuria in a patient with cyanotic heart disease nephropathy. Clin Nephrol. 2003;60:222–3.PubMed
Metadata
Title
Successful initiation and maintenance of hemodialysis in an adult patient with complete transposition of the great arteries
Authors
Shunsuke Yamada
Hideki Yotsueda
Masatomo Taniguchi
Kazuhiko Tsuruya
Hideki Hirakata
Mitsuo Iida
Publication date
01-10-2010
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2010
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-010-0315-y

Other articles of this Issue 5/2010

Clinical and Experimental Nephrology 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.